A

Akari Therapeutics plc
D

AKTX

1.00000
USD
0.01
(0.50%)
Market Closed
Volume
0
EPS
-3
Div Yield
-
P/E
-0
Market Cap
26,471,960
OverviewSignalsIdeasNews
Related Instruments
    A
    ACER
    0
    (0%)
    0.000000 USD
    A
    ACRX
    0
    (0%)
    0.000000 USD
    A
    ADMA
    0.125
    (0.72%)
    17.565 USD
    A
    ARCT
    0.560
    (3.61%)
    16.060 USD
    A
    ARWR
    0.150
    (0.77%)
    19.600 USD
    A
    AXSM
    -4.280
    (-4.71%)
    86.560 USD
    C
    CAPR
    0.260
    (1.99%)
    13.340 USD
    C
    CPRX
    0.140
    (0.66%)
    21.410 USD
    I
    IMV
    0.01000
    (1.96%)
    0.51000 USD
    More
News

Title: Akari Therapeutics plc

Sector: Healthcare
Industry: Biotechnology
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).